These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 29199173)
21. Persistent reflux symptoms in the proton pump inhibitor era: the changing face of gastroesophageal reflux disease. Dellon ES; Shaheen NJ Gastroenterology; 2010 Jul; 139(1):7-13.e3. PubMed ID: 20493864 [No Abstract] [Full Text] [Related]
22. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring. Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873 [TBL] [Abstract][Full Text] [Related]
23. Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease. Okuyama M; Nakahara K; Iwakura N; Hasegawa T; Oyama M; Inoue A; Ishizu H; Satoh H; Fujiwara Y Digestion; 2017; 95(4):281-287. PubMed ID: 28501868 [TBL] [Abstract][Full Text] [Related]
24. [Insufficient symptom control under long-term treatment with PPI in GERD - fact or fiction?]. Labenz J; Labenz G; Stephan D; Willeke F; MMW Fortschr Med; 2016 May; 158 Suppl 4():7-11. PubMed ID: 27221555 [TBL] [Abstract][Full Text] [Related]
25. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768 [TBL] [Abstract][Full Text] [Related]
26. The relationship between type 2 diabetes mellitus and failure to proton pump inhibitor treatment in gastroesophageal reflux disease. Hershcovici T; Jha LK; Gadam R; Cui H; Gerson L; Thomson S; Fass R J Clin Gastroenterol; 2012 Sep; 46(8):662-8. PubMed ID: 22858518 [TBL] [Abstract][Full Text] [Related]
27. Silent acid reflux and asthma control. Asano K; Suzuki H N Engl J Med; 2009 Apr; 360(15):1551-3. PubMed ID: 19357411 [No Abstract] [Full Text] [Related]
28. Management of gastro-oesophageal reflux disease symptoms that do not respond to proton pump inhibitors. Woodland P; Sifrim D Curr Opin Gastroenterol; 2013 Jul; 29(4):431-6. PubMed ID: 23549342 [TBL] [Abstract][Full Text] [Related]
29. Gastroesophageal reflux disease: endoscopy, duration of treatment, and choice of PPI. Greenspan NR Med Health R I; 2011 Apr; 94(4):92-4. PubMed ID: 21667598 [No Abstract] [Full Text] [Related]
30. [Inadequate response to proton pump inhibitor therapy: causes and patient management tactics]. Evsyutina YV; Trukhmanov AS Ter Arkh; 2015; 87(2):85-89. PubMed ID: 25864356 [TBL] [Abstract][Full Text] [Related]
31. [Gastroesophageal reflux disease--diagnosis and management]. Wojtuń S; Gil J; Jałocha Ł; Błaszak A; Wojtkowiak M Pol Merkur Lekarski; 2009 May; 26(155):512-6. PubMed ID: 19606713 [TBL] [Abstract][Full Text] [Related]
32. [Evidence and uncertainties on the clinical use of proton pump inhibitors]. de Prados CM Gastroenterol Hepatol; 2010 May; 33 Suppl 1():5-10. PubMed ID: 20728783 [TBL] [Abstract][Full Text] [Related]
33. Patients with refractory reflux symptoms: What do they have and how should they be managed? Kahrilas PJ; Keefer L; Pandolfino JE Neurogastroenterol Motil; 2015 Sep; 27(9):1195-201. PubMed ID: 26303047 [TBL] [Abstract][Full Text] [Related]